AC Immune S.A. logo

AC Immune S.A.

ACIU | NASDAQ
Chart Builder DCF Calculator
$2.65
+$0.02 (+0.76%)
At close: Sep 21, 2026, 4:00 PM ET
$2.65
$0 (+0.19%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$270.21M
Enterprise Value
$147.16M
Beta
1.60
Average Volume
256.48K
Shares Outstanding (Diluted)
98.67M
Shares Change YoY
-1.95%
Institutional Ownership
25.42%
Exchange
NASDAQ
ISIN
CH0329023102

Price Performance

Price Change 1M
-8.9%
Price Change 3M
8.2%
Price Change 6M
-9.9%
Price Change YTD
-21.1%
Price Change 1Y
4.7%
Price Change 3Y
-10.8%
Price Change 5Y
-61.6%
1M CAGR (ann.)
12.7%
1Y CAGR (ann.)
5.6%
5Y CAGR (ann.)
-17.5%
All-Time CAGR
-16.3%

Valuation

PE Ratio
-4.89
Forward PE
10.25
PEG Ratio
0.25
Forward PEG
0.03
PS Ratio
12.24
Forward PS
2.50
PB Ratio
6.21
P/FCF Ratio
-6.13
P/Adj. FCF Ratio
-5.70
P/OCF Ratio
-6.00
EV/Sales
8.40
EV/EBIT
-3.42
EV/EBITDA
-3.50
EV/FCF
-4.21
Earnings Yield
-19.7%
FCF Yield
-15.7%
Adj. FCF Yield
-16.9%

Financial Health

Net Cash
CHF75.36M
Total Debt
CHF4.1M
Cash & Short-Term Investments
CHF75.36M
Total Assets
CHF150.4M
Current Ratio
0.93
Quick Ratio
0.93
Debt / Equity Ratio
0.12
Debt / EBITDA
-0.10
Debt / FCF
-0.12
OCF / Debt
-8.48
Interest Coverage
-263.40
Altman Z-Score
-3.94
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
100.0%
Operating Profit Margin
-252.3%
EBITDA Margin
-239.8%
Net Profit Margin
-246.5%
FCF Margin
-199.6%
Adj. FCF Margin
-214.6%
SBC / Revenue
15.0%
SBC Impact (per share)
-7.5%

Returns

Return on Assets
-28.7%
Return on Equity
-99.2%
Return on Invested Capital
-86.6%
Return on Capital Employed
-88.0%
Return on Tangible Assets
-43.2%

Historical Growth (CAGR)

Revenue CAGR 3Y
64.5%
Revenue CAGR 5Y
53.3%
Revenue CAGR 10Y
-9.0%
EPS CAGR 3Y
20.9%
EPS CAGR 5Y
20.8%
EPS CAGR 10Y
-4.3%
FCF CAGR 3Y
-339.7%
FCF CAGR 5Y
29.6%
FCF CAGR 10Y
-6.4%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
9
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
62.3%
Earnings Date
Nov 2, 2026
EPS Estimate (next Q)
-$0.27
EPS Growth Est (next Q)
10.0%
Revenue Est (next Q)
$295.22K
Revenue Growth Est (next Q)
-79.4%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$8.33
Price Target Upside
214.3%

Cash Flow

Operating Cash Flow
CHF-34.79M
Free Cash Flow
CHF-34.95M
Adj. Free Cash Flow
CHF-37.58M
FCF Per Share
-$0.35
OCF Per Share
-$0.35
OCF/S Ratio
-198.7%

Income Statement

Revenue
CHF17.51M
Gross Profit
CHF17.51M
Operating Income
CHF-44.17M
EBITDA
CHF-42M
Net Income
CHF-43.16M
EPS (Diluted)
-$0.43
Revenue / Employee
$165.18K
Profit / Employee
$-407.15K
Employees
106

© 2026 bestshares.com. All rights reserved.